Therapy Areas: Infectious Diseases
22 March 2019 - - US-based antibiotics developer Oragenics, Inc. (NYSE American: OGEN) has priced an underwritten public offering of 16,666,668 shares of common stock, short-term warrants to purchase ...
22 March 2019 - GenePOC Inc disclosed on Thursday the receipt of approval from the US FDA for the GenePOC Strep A assay to be used along with the revogene device.The Group A Streptococcus (GAS) infect...
21 March 2019 - - US-based drug developer Forma Therapeutics has appointed Frank D. Lee as chief executive officer, starting on March 27, 2019, the company said.

Lee succeeds Steve Tregay...
21 March 2019 - - French biotechnology company Transgene (Euronext Paris: TNG) (PAR: TNG) has secured a EUR 20m revolving credit facility with Natixis, the French Corporate and Investment bank, the co...
19 March 2019 - - US-based Oragenics, Inc. (NYSE American: OGEN), a developer of new antibiotics against infectious diseases and effective treatments for oral mucositis, has enrolled the 60th pat...
15 March 2019 - - Canada-based therapeutic antibodies developer AbCellera has inked a two-year agreement with the Bill and Melinda Gates Foundation to help accelerate global health research, the ...
Related Headlines